Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
Saved in:
| Title: | Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer. |
|---|---|
| Authors: | Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Parshad S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Zhan L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Sim HW; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, and NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Ausutralia., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Shapiro JD; Department of Medical Oncology, Cabrini Hospital, Cabrini Monash University, Melbourne, Australia., Price TJ; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia., Jonker DJ; Ottawa Hospital Research Institute, University of Ottawa, Ottawa ON., Karapetis CS; Flinders Medical Center, Flinders University, Adelaide, South Australia., Strickland AH; Monash Cancer Centre, Monash University, Clayton, Australia., Zhang W; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Jeffery M; Canterbury Regional Cancer and Hematology Service Centre, Christchurch Hospital, Christchurch, New Zealand., Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, ON., Ng S; Sir Charles Gairdner Hospital, Nedlands, Australia., Sabesan S; Townsville Hospital, Townsville, Australia., Shannon J; Nepean Cancer Care Centre, Kingswood, Australia., Townsend A; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia., O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, ON., Chen EX; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON. Electronic address: eric.chen@uhn.ca. |
| Source: | Clinical colorectal cancer [Clin Colorectal Cancer] 2023 Dec; Vol. 22 (4), pp. 457-463. Date of Electronic Publication: 2023 Aug 23. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1938-0674 |
|---|---|
| DOI: | 10.1016/j.clcc.2023.08.006 |
